Product Information
LUBIPROSTONE 24 MCG CAPSULE is a generic product labeled by Natco Pharma USA LLC, priced at $0.6239 per EA under NDC 69339016317. Its NADAC has been published 197 times since Nov 16, 2022.
FDA first approved this application on Jan 31, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
24 ug/1
Manufacturer
Natco Pharma USA LLCNDC
69339016317
Classification
Generic
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LUBIPROSTONEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021908FDA Approved
1/31/2006
TE Code
AB
On Market Since
10/17/2022
Pharmacological Classes
Price Statistics
The NADAC for LUBIPROSTONE 24 MCG CAPSULE has been published 197 times since Nov 16, 2022, and over the history we have for it it has declined 85.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6239 per EA |
|---|---|
| All-time high | $4.5093 (Dec 14, 2022) |
| All-time low | $0.5868 (Nov 20, 2024) |
| 52-week high | $0.8250 |
| 52-week low | $0.6239 |
| Median price | $0.8478 |
| Average price | $1.3705 |
| Largest weekly change | +44.9% (Nov 22, 2023) |
| Weeks tracked | 197 |
| Tracking since | Nov 16, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the LUBIPROSTONE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LUBIPROSTONE 24 MCG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LUBIPROSTONE 24 MCG CAPSULE, manufactured by Natco Pharma USA LLC, is $0.6239 per EA (NDC 69339016317), effective Aug 19, 2026.
How has the price of LUBIPROSTONE 24 MCG CAPSULE changed over time?
Over the history we have for it, the NADAC for LUBIPROSTONE 24 MCG CAPSULE has declined 85.9%. It has been tracked across 197 weekly CMS publications since Nov 16, 2022.
What are the highest and lowest recorded NADAC prices for LUBIPROSTONE 24 MCG CAPSULE?
Since Nov 16, 2022, the NADAC for LUBIPROSTONE 24 MCG CAPSULE has ranged from a low of $0.5868 (Nov 20, 2024) to a high of $4.5093 (Dec 14, 2022), with a median of $0.8478 per EA.
Are there cheaper alternatives to LUBIPROSTONE 24 MCG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of LUBIPROSTONE 24 MCG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LUBIPROSTONE 24 MCG CAPSULE?
LUBIPROSTONE 24 MCG CAPSULE (NDC 69339016317) is labeled by Natco Pharma USA LLC, and CMS classifies it as a generic product.